184 related articles for article (PubMed ID: 29851188)
1. Epidemiology and patient characteristics of hepatitis D virus infection in the West of Scotland 2011-2016.
Jackson C; Gunson RN; Bradley-Stewart A; Bennett S; Black H; Kennedy N; Bell DJ
J Viral Hepat; 2018 Nov; 25(11):1395-1396. PubMed ID: 29851188
[No Abstract] [Full Text] [Related]
2. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
Goyal A; Murray JM
Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis D virus in Uzbekistan.
Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Said S; Shahnoza A; Ismoilov U; Caviglia GP; Rizzetto M; Musabaev E
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):238-240. PubMed ID: 32061325
[No Abstract] [Full Text] [Related]
4. [Hepatitis D: forgotten but not gone].
Moradpour D; Negro F
Rev Med Suisse; 2010 Sep; 6(261):1656-9. PubMed ID: 20939399
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis delta virus among hemodialysis and renal transplant patients.
Pierre AMMA; Feldner ACCA; Carvalho Filho RJ; Lopes EPA; Gouvea MSG; Pinho JRR; Carvente CT; Emori CT; Silva GAD; Ferraz MLCG
Int J Artif Organs; 2018 Mar; 41(3):171-174. PubMed ID: 29546807
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.
Liao B; Zhang F; Lin S; He H; Liu Y; Zhang J; Xu Y; Yi J; Chen Y; Liu H; Wang Z; Cai W
PLoS One; 2014; 9(12):e115888. PubMed ID: 25532128
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis D revival.
Wedemeyer H
Liver Int; 2011 Jan; 31 Suppl 1():140-4. PubMed ID: 21205152
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of and New Therapies for Hepatitis D.
Koh C; Heller T; Glenn JS
Gastroenterology; 2019 Jan; 156(2):461-476.e1. PubMed ID: 30342879
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genotyping of hepatitis B virus: a cross-sectional study conducted with female sex workers in the Marajó Archipelago, Brazil.
Frade PC; Raiol NC; da Costa LM; Pinheiro LM; Silva-Oliveira GC; Pinho JR; Lemos JA; Martins LC; Oliveira-Filho AB
Int J STD AIDS; 2019 Aug; 30(9):902-910. PubMed ID: 31226914
[No Abstract] [Full Text] [Related]
11. [Protocol for the antiviral therapy of hepatitis B and D].
; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
[No Abstract] [Full Text] [Related]
12. HBV/HDV Coinfection: A Challenge for Therapeutics.
Koh C; Da BL; Glenn JS
Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis D in Pakistan.
Abbas Z
J Coll Physicians Surg Pak; 2012 Sep; 22(9):547-8. PubMed ID: 22980605
[No Abstract] [Full Text] [Related]
14. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
[TBL] [Abstract][Full Text] [Related]
15. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis D.
Husa P; Linhartová A; Nemecek V; Husová L
Acta Virol; 2005; 49(4):219-25. PubMed ID: 16402678
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis delta in Switzerland: a silent epidemic.
Genné D; Rossi I
Swiss Med Wkly; 2011; 141():w13176. PubMed ID: 21416410
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis D diagnostics:Utilization and testing in the United States.
Safaie P; Razeghi S; Rouster SD; Privitera I; Sherman KE
Virus Res; 2018 May; 250():114-117. PubMed ID: 29596839
[TBL] [Abstract][Full Text] [Related]
19. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
Keskin O; Wedemeyer H; Tüzün A; Zachou K; Deda X; Dalekos GN; Heidrich B; Pehlivan S; Zeuzem S; Yalçın K; Gürel S; Tabak F; Idilman R; Bozkaya H; Manns M; Yurdaydin C
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2342-49.e1-2. PubMed ID: 26044319
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.
Nguyen HM; Sy BT; Trung NT; Hoan NX; Wedemeyer H; Velavan TP; Bock CT
PLoS One; 2017; 12(4):e0175304. PubMed ID: 28403190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
